Kindred Biosciences Inc (NASDAQ:KIN)

9.21
Delayed Data
As of 3:59pm ET
 +0.02 / +0.22%
Today’s Change
3.20
Today|||52-Week Range
9.28
+113.69%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Kindred Biosciences Inc have a median target of 9.25, with a high estimate of 15.25 and a low estimate of 9.00. The median estimate represents a +0.43% increase from the last price of 9.21.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Kindred Biosciences Inc. This rating has held steady since June, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$5.4M
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.21%
 
 
 
 
 
 
Growthannually -40.78%
 
 
 
 
 
 

Sales

Growthquarterly 125.62%
 
 
 
 
 
 
Growthannually -52.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.